StephenIrwinDeutschMD

PubMed

• 11 citations
  Current status of NMDA antagonist interventions in the treatment of nonketotic hyperglycinemia
  Stephen I. Deutsch, Richard B. Rosse, John Mastropaolo
  Clinical Neuropharmacology. 1998-03-01
• 31 citations
  Neuromotor and cognitive responses of adults with autism spectrum disorder compared to neurotypical adults.
  Steven Morrison, Cortney N. Armitano, C. Teal Raffaele, Stephen I. Deutsch, Serina A. Neumann
  Experimental Brain Research. 2018-06-06
• 24 citations
  Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophrenia.
  Richard B. Rosse, Barbara L. Schwartz, Susan Zlotolow, Miriam Banay-Schwartz, Anton C. Trinidad
  Clinical Neuropharmacology. 1992-04-01

Journal Articles

• Characterization of gait and olfactory behaviors in Balb/ c mouse model of autism spectrum disorders  
  Burket JA, Young C, Green T, Benson A, Deutsch SI, Brain Research Bulletin, 1/1/2016
• Experimental Assessment of Mouse Sociability Using an Automated Image Processing Approach  
  Varghese F, Burket JA, Benson AD, Deutsch SI, Zemlin CW, Journal of Visualized Experiments, 1/1/2016
• Age-Dependent Effects on Social Interaction of NMDA GluN2A Receptor Subtype-Selective Antagonism  
  Green TL, Burket JA, Deutsch SI, Brain Research Bulletin, 1/1/2016
• A Trial of D-Cycloserine to Treat the Social Deficit in Older Adolescents and Young Adults with Autism Spectrum Disorders  
  Urbano MR, Okwara L, Manser P, Hartmann K, Deutsch SI, J Neuropsychiatry Clin Neurosci, 1/1/2015
•  
  Deutsch SI, Burket JA, Urbano MR, Benson AD, Biochem Pharmacol, 1/1/2015
• NMDA Agonists for Autism Spectrum Disorders: Progress and Possibilities  
  Deutsch SI, Burket JA, Benson AD, Urbano MR, Deutsch SI, Burket JA, Benson AD, Urbano MR, 1/1/2015
• Safety of Paliperidone Extended-release in Patients with Schizophrenia or Schizoaffective Disorder and Hepatic Disease  
  Amatniek J, Canuso CM, Deutsch SI, Henderson DC, Mao L, Mikesell C, Rodriguez S, Sheehan J, Alphs L, Clinical Schizophrenia and Related Psychosis, 1/1/2013
• Recent Advances in Autism Spectrum Disorder – Volume I  
  Urbano MR, Hartmann K, Deutsch SI, Polychronopoulos GMB, Dorbin V, 1/1/2013
• Clinical Outcomes of Mild Isolated Cerebral Ventriculomegaly in the Presence of Other Neurodevelopmental Risk Factors  
  Ball, J.D., Abuhamad, A.Z., Mason, J.L., Burket, J.A., Katz, E., Deutsch, S.I, Journal of Ultrasound in Medicine, 1/1/2013
• D-Cycloserine Improves Sociability in the BTBR T+ Itpr3tf/J Mouse Model of Autism Spectrum Disorders with Altered Ras/Raf/ERK1/2 Signaling  
  Burket, J.A., Benson, A.D., Tang, A.H., Deutsch, SI, Brain Res Bulletin, 1/1/2013
• Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy  
  Deutsch, SI., Schwartz, BL., Schooler, NR, Brown, CH, Rosse, RB, Rosse, SM, Schizophrenia Research, 1/1/2013
• Balb/c mice treated with d-cycloserine arouse increased social interest in conspecifics  
  Benson, A.D., Burket, J., Deutsch, S.I., Brain Research Bulletin, 1/1/2013
• Rapamycin improves sociability in the BTBR T+Itpr3tf/J mouse model of autism spectrum disorders  
  Burket, J.A., Benson, A.D., Tang, A.H., Deutsch, SI, Brain Res Bulletin, 1/1/2013
• Mouse Models have Limitations for Development of Medications for Autism Spectrum Disorders, but also Much Promise!  
  Deutsch SI, Urbano MR, Zemlin C, Future Neurology, 1/1/2012
• Pharmacotherapeutic Implications of the Association between Genomic Instability at Chromosome 15q133 and Autism Spectrum Disorders  
  Deutsch SI, Urbano MR, Burket JA, Herndon AL, Winebarger EE, Clinical Neuropharmacology, 1/1/2012
• D-Cycloserine Improves Sociability and Spontaneous Stereotypic Behaviors in 4-Week Old Mice  
  Deutsch SI, Pepe GJ, Burket, JA, Winebarger EE, Herndon AL, Benson AD, Brain Research, 1/1/2012
• D-Cycloserine Improves the Impaired Sociability of the Balb/c Mouse  
  Deutsch SI, Burket JA, Jacome LF, Cannon WR, Herndon AL, Brain Research Bulletin, 1/1/2011
• D-serine Improves Dimensions of the Sociability Deficit of the Genetically-Inbred Balb/c Mouse Strain  
  Jacome LF, Burket JA, Herndon AL, Cannon WR, Deutsch SI, Brain Research Bulletin, 1/1/2011
• D-Cycloserine Enhances Social Exploration in the Balb/c Mouse  
  Jacome LF, Burket JA, Herndon AL, Deutsch SI, Brain Research Bulletin, 1/1/2011
• Selective mGluR5 Antagonism Attenuates the Stress-Induced Reduction of MK-801's Antiseizure Potency in the Genetically-Inbred Balb/c Mouse  
  Deutsch SI., Burket JA, Cannon WR, Jacome LF, Epilepsy & Behavior, 1/1/2011
• Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: Possible implications for the pharmacotherapy of autism spectrum disorders  
  Burket JA, Herndon AL, Winebarger EE, Jacome LF, Deutsch SI, Brain Research Bulletin, 1/1/2011
• Genetically-Inbred Balb/c Mice Differ from Outbred Swiss Webster Mice on Discrete Measures of Sociability: Relevance to a Genetic Mouse Model of Autism Spectrum Disorders  
  Jacome LF, Burket JA, Herndon AL, Deutsch SI, Autism Research, 1/1/2011
• Regulation of Intermittent Oscillatory Activity of Pyramidal Cell Neurons by GABA Inhibitory Interneurons is Impaired in Schizophrenia: Rationale for Pharmacotherapeut...  
  Deutsch SI, Rosse RB, Schwartz BL, Mastropaolo J, Burket JA, Weizman A, Israel Journal of Psychiatry, 1/1/2010
• Cholinergic Abnormalities in Autism: Is There a Rational for Selective Nicotinic Agonist Interventions?  
  Deutsch, SI., Urbano, M.R., Neumann, S.A., Burket, J.A., Katz E, Clin Neuropharmacol, 1/1/2010
• The Mental Status Exam in Talmudic Medicine  
  Deutsch, SI, CNS Spectrums, 1/1/2010
• Join now to see all

Books/Book Chapters

• Comprehensive Guide to Autism 
  Chapter: Nicotinic Acetylcholine Receptors in Autism Spectrum Disorders: Therapeutic Implicatons 
  Page 755 - 777Deutsch, SI, Schwartz B, Urbano M, Burket J, Benson A, Herndon AEditors: Patel V., Preedy V., Martin C.Patel V., Preedy V., Martin C2014
• Neural basis of implicit memory for socio-emotional information in schizophrenia 
  Schwartz BL, Vaidya CJ, Shook D, Deutsch SI2013
• The Black Book Guide to the Mental Status Examination 
  Deutsch SI, Rosse RB, Deutsch LH, Schwartz BLMBL Communications, Inc., New York, NY2009
• The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 
  Chapter: Schizophrenia Endophenotypes as Treatment Targets 
  Page 113 - 122Deutsch SI, Schwartz BL, Rosse RB, Mastropaolo J, Fanous AH, Weizman A, Burket JA, Gaskins BLEditors: Ritsner MS.Springer2009
• Focus on Mental Retardation 
  Chapter: Pharmacological modulation of GABA, glutamate and acetylcholine receptor-mediated neurotransmission holds promise for the development of novel medication strategies for mental retardation: overview an 
  Page 1 - 27Deutsch SI, Rosse RB, Schwartz BL, Mastropaolo J, Long KD, Gaskins BLEditors: Carson MI.Nova Science Publishers, Inc., New York, NY2007
• Focus on Signal Transduction Research 
  Chapter: NMDA receptor hypofunction in schizophrenia: from mouse to man 
  Page 103 - 122Deutsch SI, Mastropaolo J, Schwartz BL, Rosse RB, Gaskins BEditors: McAlpine G.Nova Science Publishers, Inc., New York, NY2007
• Contemporary Clinical Neuroscience: Transgenic and Knockout Models of Neuropsychiatric Disorders 
  Chapter: Animal Models 
  Page 193 - 220Deutsch SI, Long K, Rosse RB, Tizabi Y, Weizman R, Eller J, Mastropaolo JEditors: Fisch GS, Flint J.The Humana Press, Inc., Totowa, NJ2006
• Obsessive-compulsive disorder and its comorbid disorders 
  Chapter: Obsessive-compulsive disorder and major depression; Associated and different 
  Page 5 - 15Rosse RB, Deutsch LH, Weizman A, Eller JL, Deutsch SIEditors: Gross-Isseroff R and Weizman A.Nova Science Publishers, Inc.2006
• Basic and Applied Memory Research: Volume 2, Practical Applications 
  Chapter: The NMDA receptor complex: enhancement of memory in aging and dementia 
  Page 423 - 437Schwartz BL, Hashtroudi S, Herting RL, Fakouhi TD, Deutsch SIEditors: Herrmann D, McEvoy C, Hertzog C, Hertel P, Johnson M.Lawrence Erlbaum Associates, Inc., Mahwah, NJ1996
• Advances in the neurobiology of schizophrenia 
  Chapter: Biological factors in schizophrenia with childhood onset: predictive value for psychopathology in adulthood 
  Page 401 - 427Deutsch SI, Armenteros JL, Campbell MEditors: den Boer JA, Westenberg HGM, and van Praag HM.John Wiley & Sons, New York, NY1995
• Comprehensive Textbook of Psychiatry 
  Chapter: Medical assessment and laboratory testing in psychiatry 
  Page 601 - 619Rosse RB, Deutsch LH, Deutsch SIEditors: Sadock B and Kaplan HI.Williams and Wilkins1995
• The Biochemical Basis of Pediatric Diseases 
  Chapter: Neurologic and psychiatric disorders 
  Page 293 - 320Packer RJ, Deutsch SIEditors: Soldin SJ, Rifai N, Hicks JM.American Association for Clinical Chemistry Press, Washington, DC1992
• Foundations of Psychiatry 
  Chapter: Neurophysiological and neurochemical basis of behavior 
  Page 67 - 86Murphy M, Deutsch SIEditors: Davis KL, Klar H, Coyle JT.W.B. Saunders Company, Philadelphia, PA1991
• Application of basic neuroscience to child psychiatry 
  Chapter: Biological studies of attention deficit disorder 
  Page 231 - 239Weizman R, Weizman A, Deutsch SIEditors: Deutsch SI, Weizman A, Weizman R.Plenum Publishing Corporation, New York, NY1990
• Application of basic neuroscience to child psychiatry 
  Chapter: Biological studies of schizophrenia with childhood onset 
  Page 217 - 229Green WH, Deutsch SIEditors: Deutsch SI, Weizman A, Weizman R.Plenum Publishing Corporation, New York, NY1990
• Application of basic neuroscience to child psychiatry 
  Chapter: Nonketotic hyperglycinemia: a paradigm for the application of neuroscience to the understanding and treatment of a developmental disorder 
  Page 165 - 180Deutsch SI, Deutsch LH, Weizman REditors: Deutsch SI, Weizman A, Weizman R.Plenum Publishing Corporation, New York, NY1990
• Application of basic neuroscience to child psychiatry 
  Chapter: Neuroendocrine abnormalities in autism and schizophrenic disorder of childhood 
  Page 153 - 160Weizman R, Deutsch LH, Deutsch SIEditors: Deutsch SI, Weizman A, Weizman R.Plenum Publishing Corporation, New York, NY1990
• Application of basic neuroscience to child psychiatry 
  Chapter: The role of the GABA/benzodiazepine receptor complex in stress: in vivo approaches and potential relevance to childhood psychopathology 
  Page 61 - 76Deutsch SI, Weizman A, Weizman R, Vocci FJ, Jr., Kook KAPlenum Publishing Corporation, New York, NY1990
• Laboratory diagnostic testing in psychiatry 
  Rosse RB, Giese AA, Deutsch SI, Morihisa JMAmerican Psychiatric Press, Inc., Washington, DC1989
• Neuronal Control of Bodily Functions: Basic and Clinical Aspects. Frontiers of Stress Research (Vol. III) 
  Chapter: Molecular mechanisms of stress and anxiety: alterations in the Benzodiazepine/GABA receptor complex 
  Page 148 - 159Drugan RC, Deutsch SI, Weizman A, Weizman R, Vocci FJ, Crawley JN, Skolnick P, Paul SMEditors: H. Weiner, I. Florin, R. Murison, D. Hellhammer.Hans Huber Publishers, Toronto, Ontario, Canada1989
• New Concepts in Depression 
  Chapter: The Benzodiazepine/GABA receptor complex in experimental stress, anxiety and depression 
  Page 351 - 362Deutsch SI, Drugan RC, Vocci FJ, Jr., Weizman A, Weizman R, Crawley JN, Skolnick P, Paul SMEditors: Briley M.The MacMillan Press LTD, London, UK1988
• Handbook of Clinical Psychoneuro-endocrinology 
  Chapter: Psychosocial dwarfism, infantile autism, and attention deficit disorder 
  Page 109 - 142Green WH, Deutsch SI, Campbell MEditors: Nemeroff CH, Loosen PT.Guilford Press, New York, NY1987
• Handbook of Autism and Disorders of Atypical Development 
  Chapter: Psychopharmacology 
  Page 545 - 565Campbell M, Anderson LT, Green WH, Deutsch SIEditors: Cohen DJ, Donnellan AM.Wiley and Sons, New York, NY1987
• Drugs in Psychiatry, Antipsychotics (Vol 3) 
  Chapter: Neuroleptics in children 
  Page 213 - 238Campbell M, Deutsch SIEditors: Burrows GD, Norman T, Davis B.Elsevier, New York, NY1985
• Child and Adolescent Psychopharmacology 
  Campbell M, Green WH, Deutsch SISage Publications, Inc., Beverly Hills, CA1985
• Join now to see all

Abstracts/Posters

• Characterization of Olfactory and Gait Behaviors in the Balb/c Mouse Model of Autism Spectrum Disorders
  J. Burket J., Young C.,Benson A., Green,T., Deutsch SI, 54th Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, FL, 1/10/2015
• Improves Sociability in the BTBR T+ Itpr3tf/J Mouse Model of Autism Spectrum Disorders with Altered Ras/Raf/ERK1/2 Signaling
  Burket, J.A., Benson, A.D., Tang, A.H., Deutsch, S.I, CINP Thematic Meeting on Pharmacogenomics and Personalised Medicine in Psychiatry, Jerusalem, Israel, 1/21/2013
• Rapamycin, an Inhibitor of mTORC1 Signaling Activity, Improved Measures of Sociability in the BTBR T+ Itpr3tf/J Mouse Model of Autism Spectrum Disorder
  Burket, J.A., Benson, A.D., Tang, A.H., Deutsch, S.I, 52nd Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, FL, 1/12/2013
• D-Cycloserine Improves Sociability and Spontaneous Stereotypic Behaviors in 4-Week Old Mice
  Deutsch SI, Pepe GJ, Burket JA, Winebarger EE, Herndon AL, Benson AD, 67th Annual Meeting of the Society of Biological Psychiatry; 165th Annual Meeting of the American Psychiatric Association, Philadelphia, PA, 1/8/2012
• An intervention to test the alpha7 nicotinic receptor model in Schizophrenia: CDP-choline, a cholinergic agonist, and galantamin, a positive allosteric modulator
  Deutsch SI, Schooler NR, Schwartz B, Brown CH, Rosse SM, Rosse RB, 50th Annual Meeting of the American College of Neuropsychopharmacology, Honolulu, HI, 1/8/2011
• The effects of prolonged administration of an alhpa7 nicotinic cholingeric agonist intervention on neurocognitive function in Schizophrenia
  Schwartz B, Deutsch SI, Schooler NR, Rosse SM, Brown CH, Rosse RB, 50th Annual Meeting of the American College of Neuropsychopharmacology, Honolulu, HI, 1/8/2011
• Selective mGluR5 antagonism attenuates the stress-induced reduction of MK-801’s antiseizure potency in the genetically-inbred Balb/c mouse
  Burket JA, Deutsch SI, Cannon WR, Jacome LF, 49th Annual Meeting of the American College of Neuropsychopharmacology, Miami Beach, FL, 1/9/2010
• D-Cycloserine improves the impaired sociability of the Balb/c mouse
  Deutsch SI, Burket JA, Jacome L, Cannon WR, Herndon AL, 49th Annual Meeting of the American College of Neuropsychopharmacology, Miami Beach, FL, 1/9/2010
• Implicit learning of socio-emotional stimuli in schizophrenia: behavioral and fMRI findings
  Schwartz B, Vaidya C, Howard J, Jr., Deutsch S, 49th Annual Meeting of the American College of Neuropsychopharmacology, Miami Beach, FL, 1/9/2010
• NMDA NR2B subtype-selective receptor antagonists fail to antagonize electrically-precipitated seizures and elicit popping in mice
  Deutsch SI , Burket JA, Mastropaolo J, Rosse RB, Katz EU, 48th Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, FL, 1/10/2009
• Sodium butyrate, an epigenetic interventional strategy, attenuates a stress-induced alteration of MK-801’s pharmacologic action
  Deutsch SI, Rosse RB, Long KD, Gaskins BL, Burket JA, Mastropaolo J, Deutsch SI, Rosse RB, Long KD, Gaskins BL, Burket JA, Mastropaolo J, Boca Raton, FL, 1/13/2007
• Deutsch SI, Schwartz BL, Schooler NR, Rosse RB, Mastropaolo J, Gaskins BL, Neuropsychopharmacology, 1/1/2006
• Stress and genetic factors interact to modulate effects of D-serine, sarcosine, and guanosine on NMDA receptor function in intact mice: Relevance to schizophrenia
  Mastropaolo J, Rosse RB, Long KD, Deutsch SI, Neuropsychopharmacology, 1/1/2006
• An open label pilot study of the effects of galantamine on depressive symptoms in patients with chronic schizophrenia
  Nelson MW, Benham RL, Deutsch SI, Rosse RB, Schizophrenia Bulletin, 1/1/2005
• Adjuvant therapeutic effects of galantamine on negative symptoms and apathy in patients with chronic schizophrenia: an open label prospective study
  Deutsch SI, Nelson MW, Rosse RB, Benham RL, Schizophrenia Bulletin, 1/1/2005
• Effects of incidental processing of eye gaze and facial expression on controlled attention in schizophrenia
  Schwartz BL, Rowan MT, Vaidya CJ, Howard H, Deutsch SI, Schizophrenia Bulletin, 1/1/2005
• An Open Label Pilot Study of the Effects of Galantamine on Depressive Symptoms in Inpatients with Chronic Schizophrenia
  Nelson MW, Benham RL, Rosse RB, Deutsch SI, Neuropsychopharmacology, 1/1/2004
• Adjuvant Therapeutic Effects of Galantamine on Negative Symptoms and Apathy in Inpatients with Chronic Schizophrenia: An Open Label Prospective Study
  Deutsch SI, Nelson MW, Rosse RB, Benham RL, Neuropsychopharmacology, 1/1/2004
• Behavioral consequences of methyllycaconitine in mice: a model of alpha7 nicotionic acetylcholine receptor deficiency
  Deutsch SI, Mastropaolo J, Rosse RB, Chilton M, Bellack AS, College of Neuropsychopharmacology (ACNP), San Juan, Puerto Rico, 1/11/2003
• Topiramate and galantamine modulate NMDA receptor hypofunction in mice
  Deutsch SI, Rosse RB, Billingslea EN, Bellack AS, Mastropaolo J, Schizophrenia Research, 1/1/2003
• An open-label investigation of the adjuvant therapeutic effects of galantamine in patients with chronic schizophrenia and persistent deficit symptoms
  Arnold DS, Rosse RB, Nelson M, Dickinson D, Reynolds R, Deutsch SI, Schizophrenia Research, 1/1/2003
• The use of a mirror to provide visual feedback for producing emotions
  Mathis G, Mangold KA, Schwartz BL, Mastropaolo J, Rosse RB, Deutsch SI, Schizophrenia Research, 1/1/2003
• ontext-dependent memory impairment in schizophrenia: Analysis of the frontal dysfunction hypothesis
  Schwartz BL, Parker ES, Hovaguimian A, Williams A, Rosse RB, Deutsch SI, Schizophrenia Research, 1/1/2003
• Topiramate and galantamine modulate NMDA receptor hypofunction in mice
  Deutsch SI, Rosse RB, Billingslea EN, Bellack AS, Mastropaolo J, 41st Annual Meeting of the American College of Neuropsychopharmacology (ACNP), San Juan, Puerto Rico, 1/12/2002
• Stress and genetic mouse strain influence sensitivity to behavioral effects of MK-801: relevance to schizophrenia
  Deutsch SI, Billingslea E, Rosse RB, Bellack AS, Tizabi Y, Mastropaolo J, Biological Psychiatry, 1/1/2002
• Join now to see all

Lectures

• NMDA Receptor Activation for the Treatment of Autism Spectrum Disorders 
  Bethesda,MD - 1/29/2015
• Phenomenology and Pathophysiology of Schizophrenia 
  Virginia Beach,VA - 1/16/2015
• Effects of NMDA Activation in Mouse Models of Autism Spectrum Disorders 
  Portsmouth, VA - 1/13/2015
• Genetically-Determined Redox Dysregulation and Oxidative Stress: A Model of Gene-Environment Interaction Increasing Risk for Schizophrenia 
  1/1/2015
• Anatomic Correlates of Conversion to Psychotic Disorder in Adolescents with High Clinical Risk: Does Inflammation Play a Role? 
  1/1/2015
• PTSD, Its Clinical Description, Treatment and Underlying Pathophysiology 
  Portsmouth, VA - 1/16/2014
• Effects of VU0410120, a novel GlyT1 inhibitor, on measures of sociability, cognition and stereotypic behaviors in a mouse model of autism 
  Phoenix, AZ - 1/11/2014
• A Mother’s Touch is Irreplaceable and Critical to the Healthy Development of the Preterm Infant 
  1/1/2014
• Old Drugs for New Disorders: Novel Therapeutic Mechanisms and Insights into Pathogenesis 
  1/1/2014
• Maternal Immune Activation during Pregnancy and Risk to Offspring: Implications for Pathogenesis, Prevention and Treatment 
  1/1/2014
• Increased Intrinsic Hippocampal Resting Activity in Schizophrenia: A Biomarker of Cognitive Dysfunction and Therapeutic Target Engagement 
  1/1/2014
• CSF Biomarkers of Alzheimer’s Disease for Classification of Preclinical Disease and Target Engagement; Are We There Yet? 
  1/1/2014
• 3C Informs the 3D Structure of Chromatin; Relevance to Neuropsychiatry 
  1/1/2014
• Circuit Abnormalities Support the Existence of “Depressions” that Differ in Symptom Profile and Treatment Response 
  1/1/2014
• Love Cures All, but can Oxytocin Substitute? 
  1/1/2014
• New Neurons in the Adult Brain: What do They Mean and What do They Do? 
  1/1/2014
• Is Oxytocin the Secret to Experiencing More Pleasant Touch? Gender and Autistic Traits Modulate Oxytocin’s Ability to Make Social Touch Subjectively More Pleasant 
  1/1/2014
• Delayed and Deviant Cognitive Control in Autism Spectrum Disorders Reflect Circuit Abnormalities in the Brain 
  1/1/2014
• Speech Disrupts Facial Scanning in Infants that Develop Autism Spectrum Disorders: A Possible Prognostic Marker 
  1/1/2014
• Endocannabinoid Signaling within the Amygdala Processes Threatening Stimuli and Fear Memories: Possible Treatment Implications for PTSD and other Trauma-Related Disorders 
  1/1/2014
• Graph Theory: An Approach to Making Sense of the Connectome that is the Brain with Relevance to Understanding and Treating Neuropsychiatric Disorders 
  1/1/2014
• Remedial Reading: A Necessary Component of the Individualized, Multi-Modal, Interdisciplinary Treatment Plans of Patients with Schizophrenia 
  1/1/2014
• Serotonin 7 Receptor-Mediated Signaling Cascades Activate Rho GTPases: A Possible Treatment Strategy for Rett Syndrome and other Neuropsychiatric Disorders? 
  1/1/2014
• Mice whose Knocked Out Expression of the NMDA Receptor is Restricted to Parvalbumin-Containing GABA Interneurons Model the Psychopathological Domain of Social Deficits... 
  1/1/2014
• Oxytocin Administration to Fathers Can Improve Attachment Behaviors in Infants 
  1/1/2013
• Join now to see all

Other

• Update on Atypical Antipsychotic Medications: Differential Therapeutics 
  Deutsch SI, National Satellite TV Broadcast, The Minneapolis Geriatric Research, Education and Clinical Center (
  Minneapolis, MN - 1/3/2002